1,339
Views
105
CrossRef citations to date
0
Altmetric
Articles

Dipper and Non-Dipper Blood Pressure 24-Hour Patterns: Circadian Rhythm–Dependent Physiologic and Pathophysiologic Mechanisms

, , , , &
Pages 17-30 | Received 08 Mar 2012, Accepted 24 Apr 2012, Published online: 24 Sep 2012

REFERENCES

  • Alexiuk NA, Vriend JP. (1993). Extrahypothalamic effects of melatonin administration on serotonin and norepinephrine synthesis in female Syrian hamsters. J. Neural Transm. Gen. Sect. 94:43–53.
  • Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Di Tullio M, Marchioli R, Mariotti G, Radice M, Taioli E, Terzian E, Tognoni G, Zussino A, and the participating doctors of the ‘Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano’. (1992). Prevalence and variability of orthostatic hypotension in the elderly. Results of the ‘Italian study on blood pressure in the elderly (SPAA). Eur. Heart J. 13:178–182.
  • Alli C, Avanzini F, Bettelli G, Colombo F, Torri V, Tognoni G, and general practitioners of SPAA. (1999). The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up. Arch. Intern. Med. 159:1205–1212.
  • Angeli A, Gatti G, Masera R. (1992). Chronobiology of the hypothalamic-pituitary-adrenal and rennin-angiotensin-aldosterone systems. In Touitou Y, Haus E (eds.). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag, 292–314.
  • Arangino S, Cagnacci A, Angiolucci M, Vacca AMB, Longu G, Volpe A, Melis G. (1999). Effect of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am. J. Cardiol. 83:1417–1419.
  • Arendt J. (1992). The pineal. In Touitou Y, Haus E(eds.). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag, 349–362.
  • Arendt J. (2012). Biological rhythms during residence in polar regions. Chronobiol. Int. 29:379–394.
  • Arendt J, Paunier L, Sizonenko PC. (1975). Melatonin radioimmunoassay. J. Clin. Endocrinol. Metab. 40:347–350.
  • Asai M, Vindrola O, Zubieta M, Talavera E, Massarini A. (1988). Diurnal variations of IR-Met-enkephalin in the brain of pentylenetetrazol-kindled rats. Brain Res. 442:81–85.
  • Asai M, Zubieta M, Matamoros-Trejo G, Linares G, Agustin P. (1998). Diurnal variations of opioid peptides and synenkephalin in vitro release in the amygdala of kindled rats. Neuropeptides 32:293–299.
  • Asai MA, Lilian Mayagoitia LM, David Garcia DG, Gilberto Matamoros-Trejo GM, Marcela Valdes-Tovar MV, Phillipe Leff PL. (2007). Rat brain opioid peptides-circadian rhythm is under control of melatonin. Neuropeptides 41:389–397.
  • Aschoff J, Daan S, Groos GA. (1982). Vertebrate circadian systems. Heidelberg, Germany: Springer-Verlag, 363 pp.
  • Asmar RG, Julia PL, Mascarel VL, Fabiani JN, Benetos A, Safar ME. (1994). Ambulatory blood pressure profile after carotid endarterectomy in patients with ischaemic arterial disease. J. Hypertens. 12:697–702.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol Int. 30:340–352.
  • Barontini M, Romeo HE, Armando I, Cardinali DP. (1988). 24 hour changes in catecholamine content of rat thyroid and submaxillary glands. J. Neural Transm. 71:189–194.
  • Baumgart P, Walger P, Gerke M, Dorst KG, Vetter H, Rahn KH. (1989). Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. J. Hypertens. 7( Suppl 6):S70–S71.
  • Bode-Böger SM, Böger RH, Kielstein JT, Löffler M, Schäffer J, Frölich JC. (2000). Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. J. Invest. Med. 48:125–132.
  • Boudreau P, Yeh WH, Dumont GA, Boivin DB. (2012). A circadian rhythm in heart rate variability contributes to the increased cardiac sympathovagal response to awakening in the morning. Chronobiol. Int. 29:757–768.
  • Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JR, Litwin SE, Hardin PE, Chow CW, Chandler MP, Abel ED, Young ME. (2008). Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am. J. Physiol. Heart Circ. Physiol. 294:H1036–H1047.
  • Brickman AS, Stern N, Sowers JR. (1990). Circadian variations of catecholamines and blood pressure in patients with pseudohypoparathyroidism and hypertension. Chronobiologia 17:37–44.
  • Brunel S, de Montigny C. (1987). Diurnal rhythms in the responsiveness of hippocampal pyramidal neurons to serotonin, norepinephrine, gamma-aminobutyric acid and acetylcholine. Brain Res. Bull. 18:205–212.
  • Buijsen JG, van Acker BA, Koomen GC, Koopman MG, Arisz L. (1994). Circadian rhythm of glomerular filtration rate in patients after kidney transplantation. Nephrol. Dial. Transplant. 9:1330–1333.
  • Burnier M, Coltamai L, Maillard M, Bochud M. (2007). Renal sodium handling and nighttime blood pressure. Semin. Nephrol. 27:565–571.
  • Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB. (1998). Influences of melatonin administration on the circulation of women. Am. J. Physiol. 274:R335–R338.
  • Cagnacci A, Arangino S, Angiolucci M, Melis GB, Facchinetti F, Malmusi S, Volpe A. (2001). Effect of exogenous melatonin on vascular reactivity and nitric oxide in post menopausal women: role of hormone replacement therapy. Clin. Endocrinol. 54:26–266.
  • Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. (2005). Prolonged melatonin administration decreases nocturnal blood pressure in women. Am. J. Hypertens. 18:1614–1618.
  • Carmody JJ. (1987). Opiate receptors: an introduction. Anaesth. Intens. Care 15:27–37.
  • Caruana MP, Lahiri A, Cashman PM, Altman DG, Raftery EB. (1988). Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am. J. Cardiol. 62:755–759.
  • Cassone VM. (1990). Effects of melatonin on vertebrate circadian systems. Trends Neurosci. 13:457–464.
  • Cavalho MJ, van Den Meiracker AH, Boomsma F, Lima M, Freitas J, Veld AJ, Falcao De Freitas A. (2000). Diurnal blood pressure variation in progressive autonomic failure. Hypertension 35:892–897.
  • Chau NP, Bauduceau B, Chanudet X, Larroque P, Gautier D. (1994). Ambulatory blood pressure in diabetic subjects. Am. J. Hypertens. 7:487–491.
  • Cowen PJ, Bevan JS, Gosden B, Elliott SA. (1985). Treatment with beta adrenoceptor blockers reduces plasma melatonin concentration. Br. J. Clin. Pharmacol. 19:258–260.
  • Craft CM, Morgan WW, Reiter RJ. (1984). 24-Hour changes in catecholamine synthesis in rat and hamster pineal glands. Neuroendocrinology 38:193–198.
  • Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol Int. 30:159–175.
  • Dagre AG, Lekakis JP, Papaioannou TG, Papamichael CM, Koutras DA, Stamatelopoulos SF, Alevizaki M. (2005). Arterial stiffness is increased in subjects with hypothyroidism. Int. J. Cardiol. 103:1–6.
  • Dardente H, Cermakian N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24:195–213.
  • Deedwania PC. (1997). Circadian rhythms of cardiovascular disorders. Armonk, NY: Futura Publishing, 221 pp.
  • de la Sierra A, del Mar Lluch M, Coca A, Aguilera MT, Sánchez M, Sierra C, Urbano-Márquez A. (1995). Assessment of salt sensitivity in essential hypertension by 24-h ambulatory blood pressure monitoring. Am. J. Hypertens. 8:970–977.
  • de Leeuw PW. (2011). Nycthemeral relationship between renal function and sodium homeostasis. Cur. Hypertens. Rep. 13:136–141.
  • degli Uberti EC, Salvadori S, Trasforini G, Margutti A, Ambrosio MR, Rossi R, Portaluppi F, Pansini R. (1992). Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man. J. Clin. Endocrinol. Metab. 75:370–374.
  • degli Uberti EC, Ambrosio MR, Vergnani L, Portaluppi F, Bondanelli M, Trasforini G, Margutti A, Salvadori S. (1993). Stress-induced activation of sympathetic nervous system is attenuated by the selective δ-opioid receptor agonist deltorphin in healthy man. J. Clin. Endocrinol. Metab. 77:1490–1494.
  • Deyneli O, Yazici D, Toprak A, Yuksel M, Aydin H, Tezcan H, Yavuz DG, Akalin S. (2008). Diurnal blood pressure abnormalities are related to endothelial dysfunction in patients with non-complicated type 1 diabetes. Hypertens. Res. 31:2065–2073.
  • Dickmeis T. (2009). Glucocorticoids and the circadian clock. J. Endocrinol. 200:3–22.
  • Doba N, Reis DJ. (1974). Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat. Circ. Res. 34:293–301.
  • Dupont A, Cusan L, Garon M, Labrie F, Li CH. (1977). Beta-endorphin: stimulation of growth hormone release in vivo. Proc. Natl. Acad. Sci. U. S. A. 74:358–359.
  • Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, Garvey ME, Frangogiannis NG, Michael LH, Chow CW, Dyck JR, Young ME. (2010). Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ. Res. 106:546–550.
  • Durgan DJ, Tsai JY, Grenett MH, Pat BM, Ratcliffe WF, Villegas-Montoya C, Garvey ME, Nagendran J, Dyck JRB, Bray MS, Gamble KL, Gimble JM, Young ME. (2011). Evidence suggesting that the cardiomyocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice. Chronobiol. Int. 28:187–203.
  • Ekmekcioglu C, Thalhammer T, Mehrabi M, Glogar H, Holzenbein T, Markovic O, Leibetseder VJ, Strauss-Blasche G, Marktl W. (2003). The melatonin receptor subtype MT2 is present in the human cardiovascular system. J. Pineal Res. 35:40–44.
  • Elherik K, Khan F, McLaren M, Kennedy G, Belch JJ. (2002). Circadian variation in vascular tone and endothelial cell function in normal males. Clin. Sci. 102:547–552.
  • Elliott WJ. (1998). Circadian variation in the time of stroke onset: a meta-analysis. Stroke 29:992–996.
  • Fallo F, Fanelli G, Cipolla A, Betterle C, Boscaro M, Sonino N. (1994). 24-Hour blood pressure profile in Addison's disease. Am. J. Hypertens. 7:1105–1109.
  • Feldstein C, Akopian M, Olivieri AO, Garrido D. (2012). Association between nondipper behavior and serum calcium in hypertensive patients with mild-to-moderate chronic renal dysfunction. Clin. Exp. Hypertens. Apr 3 Epub ahead of print. doi: 10.3109/10641963.2012.665541.
  • Firsov D, Tokonami N, Bonny O. (2012). Role of the renal circadian timing system in maintaining water and electrolytes homeostasis. Mol. Cell. Endocrinol. 349:51–55.
  • Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. (1992). Nocturnal cortisol release in relation to sleep structure. Sleep 15:21–27.
  • Franklin SS, Sowers JR, Batzdorf U. (1986). Relationship between arterial blood pressure and plasma norepinephrine levels in a patient with neurogenic hypertension. Am. J. Med. 81:1105–1107.
  • Franz IW, Erb D, Tonnesmann U. (1992). Gestorte 24-Stunden-Blutdruckrhythmik bei normotensiven und hypertensiven Asthmatikern. Z. Kardiol. 81:13–16.
  • Fukuda M, Motokawa M, Miyagi S, Sengo K, Muramatsu W, Kato N, Usami T, Yoshida A, Kimura G. (2006). Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol. Dial. Transplant. 21:2172–2177.
  • Fukuda M, Wakamatsu-Yamanaka T, Mizuno M, Miura T, Tomonari T, Kato Y, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Kimura G. (2011). Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption. Am. J. Physiol. 301:F953–F957.
  • Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
  • Garcia SI, Alvarez AL, Porto PI, Garfunkel VM, Finkielman S, Pirola CJ. (2001). Antisense inhibition of thyrotropin-releasing hormone reduces arterial blood pressure in spontaneously hypertensive rats. Hypertension 37:365–370.
  • Golombek DA, Agostino PV, Plano SA, Ferreyra GA. (2004). Signaling in the mammalian circadian clock: the NO/cGMP pathway. Neurochem. Int. 45:929–936.
  • Gould BA, Raftery EB. (1991). Twenty-four-hour blood pressure control: an intraarterial review. Chronobiol. Int. 8:495–505.
  • Grandison L, Guidotti A. (1977). Regulation of prolactin release by endogenous opiates. Nature 270:357–359.
  • Granger JP, Alexander BT, Llinas M. (2002). Mechanisms of pressure natriuresis. Curr. Hypertens. Rep. 4:152–159.
  • Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. (2006). Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am. J. Med. 119:898–902.
  • Grossman E, Laudon M, Zisapel N. (2011). Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc. Health Risk Manag. 7:577–584.
  • Guerrot D, Hansel B, Perucca J, Roussel R, Bouby N, Girerd X, Bankir L. (2011). Reduced insulin secretion and nocturnal dipping of blood pressure are associated with a disturbed circadian pattern of urine excretion in metabolic syndrome. J. Clin. Endocrinol. Metab. 96:E929–E933.
  • Guo H, Cheng J, Lee JD, Ueda T, Shan J, Wang J. (2004). Relationship between hypertensive left ventricular hypertrophy, neurohormonal factors and ventricular arrhythmias in very old patients. Acta Cardiol. 59:47–50.
  • Hara K, Floras JS. (1995). Influence of naloxone on muscle sympathetic nerve activity, systemic and calf haemodynamics and ambulatory blood pressure after exercise in mild essential hypertension. J. Hypertens. 13:447–461.
  • Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137–147.
  • Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257–266.
  • Hermida RC, Fernández JR, Ayala DE, Mojón, Alonso I, Smolensky MH. (2001). Circadian rhythm of double product in healthy normotensive young subjects. Chronobiol. Int. 18:475–489.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC Study. Chronobiol. Int. 26:1629–1651.
  • Hermida RC, Ayala DE, Fernandez JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
  • Hermida RC. Chayán L, Ayala DE, Mojón A, Fontao MJ, Fernández JR. (2011b). Relation between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension. Chronobiol. Int. 28:509–519.
  • Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. (2013a). Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 30:176–191.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 30:68–86.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013c). Administration-time differences in effects of hypertensive medications on ambulatory blood pressure regulation. Chronobiol Int. 30:280–314.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013d). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 30:315–327.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol Int. 30:328–339.
  • Hermida RC, Ríos MT, Crespo JJ, Moya A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE, on behalf of the Hygia Project Investigators. (2013f). Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension. Chronobiol Int. 30:192–206.
  • Hickey MS, Costill DL, Vukovich MD, Kryzmenski K, Widrick JJ. (1993). Time of day effects on sympathoadrenal and pressor reactivity to exercise in healthy men. Eur. J. Appl. Physiol. 67:159–163.
  • Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M. (2002). Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers. J. Am. Coll. Cardiol. 40:2039–2043.
  • Hong SM, Rollag MD, Ramirez J, Stetson MH. (1993). A single injection of adrenergic agonists enhances pineal melatonin production in Turkish hamsters. J. Pineal Res. 14:138–144.
  • Idema RN, van den Meiracker AH, Balk AH, Bos E, Schalekamp MA, Man in't Veld AJ. (1994). Abnormal diurnal variation of blood pressure, cardiac output, and vascular resistance in cardiac transplant recipients. Circulation 90:2797–2803.
  • Imai Y, Abe K, Miura Y, Nihei M, Sasaki S, Minami N, Munakata M, Taira N, Sekino H, Yamakoshi K, Yoshinaga K. (1988a). Hypertensive episodes and circadian fluctuations of blood pressure in patients with phaeochromocytoma: studies by long-term blood pressure monitoring based on a volume-oscillometric method. J. Hypertens. 6:9–15.
  • Imai Y, Abe K, Sasaki S, Minami N, Nihei M, Munakata M, Murakami O, Matsue K, Sekino H, Miura Y, Yoshinaga K. (1988b). Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 12:11–19.
  • Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Nihei M, Sekino H, Yoshinaga K. (1989). Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations. J. Hypertens. 7:113–120.
  • Jaffer A, Russell VA, Taljaard JJ. (1987). Noradrenergic and dopaminergic modulation of thyrotropin secretion in the rat. Brain Res. 404:267–272.
  • Janssen BJ, Tyssen CM, Duindam H, Rietveld WJ. (1994). Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats. Physiol. Behav. 55:307–311.
  • Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. (2003). Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press. 12:19–24.
  • Kachi T, Banerji TK, Quay WB. (1984). Quantitative cytological analysis of functional changes in adrenomedullary chromaffin cells in normal, sham-operated, and pinealectomized rats in relation to time of day: I. Nucleolar size. J. Pineal Res. 1:31–49.
  • Kafka MS, Benedito MA, Roth RH, Steele LK, Wolfe WW, Catravas GN. (1986). Circadian rhythms in catecholamine metabolites and cyclic nucleotide production. Chronobiol. Int. 3:101–115.
  • Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. (2008). Causes and mechanisms of nondipping hypertension. Clin. Exp. Hypertens. 30:585–597.
  • Kario K, Mitsuhashi T, Shimada K. (2002). Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping. Am. J. Hypertens. 15:531–537.
  • Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107:1401–1406.
  • Kawano Y, Tochikubo O, Minamisawa K, Miyajima E, Ishii M. (1994). Circadian variation of hemodynamics in patients with essential hypertension: comparison between early morning and evening. J. Hypertens. 12:1405–1412.
  • Kawasaki T, Ueno M, Uezono K, Kawano Y, Abe I, Kawazoe N, Eto T, Fukiyama K, Omae T. (1984). The renin-angiotensin-aldosterone system and circadian rhythm of urine variables in normotensive and hypertensive subjects. Jpn. Circ. J. 48:168–172.
  • Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishino H, Koike H. (1987). Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin. Exp. Hypertens. A9:1121–1131.
  • Kimura G, Dohi Y, Fukuda M. (2010). Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens. Res. 33:515–520.
  • Kohara K, Nishida W, Maguchi M, Hiwada K. (1995). Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 26:808–814.
  • Kool MJ, Wijnen JA, Derkx FH, Struijker Boudier HA, Van Bortel LM. (1994). Diurnal variation in prorenin in relation to other humoral factors and hemodynamics. Am. J. Hypertens. 7:723–730.
  • Laflamme A, Wu L, Foucart S, de Chamlain J. (1998). Impaired basal sympathetic tone and alpha 1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am. J. Hypertens. 11:219–229.
  • Laubie M, Schmitt H, Vincent M, Remond G. (1977). Central cardiovascular effects of morphinomimetic peptides in dogs. Eur. J. Pharmacol. 46:67–71.
  • Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. (1985). Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 60:1210–1215.
  • Manfredini R, Gallerani M, Portaluppi F, Salmi R, Chierici F, Fersini C. (1995). Circadian variation in the occurrence of paroxysmal supraventricular tachycardia in clinically healthy subjects. Chronobiol. Int. 12:55–61.
  • Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996a). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
  • Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996b). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865–868.
  • Manfredini R, Gallerani M, Portaluppi F, Salmi R, Zamboni P, Fersini C. (1998). Circadian variation in the onset of acute critical limb ischemia. Thromb. Res. 92:163–169.
  • Manfredini R, Portaluppi F, Salmi R, Zamboni P, La Cecilia O, Kuwornu-Afi H, Regoli F, Bigoni M, Gallerani M. (1999). Seasonal variation in the occurrence of non traumatic rupture of thoracic aorta. Am. J. Emerg. Med. 17:672–674.
  • Manfredini R, Gallerani M, Boari B, Maraldi C, La Cecilia O, Rafael Ferreira AB, Smolensky MH, Portaluppi F. (2002). Morning preference in onset of symptomatic third-degree atrio-ventricular heart block. Chronobiol. Int. 19:785–791.
  • Manfredini R, Boari B, Portaluppi F. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives [letter]. Circulation 108:e72–e73.
  • Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555–559.
  • Manfredini R, Boari B, Salmi R, Fabbian F, Pala M, Tiseo R, Portaluppi F. (2013). Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol Int. 30:6–16.
  • Mann S, Altman DG, Raftery EB, Bannister R. (1983). Circadian variation of blood pressure in autonomic failure. Circulation 68:477–483.
  • Mansoor GA. (2006). Orthostatic hypotension due to autonomic disorders in the hypertension clinic. Am. J. Hypertens. 19:319–326.
  • Martinelli P, Coccagna G, Rizzuto N, Lugaresi E. (1981). Changes in systemic arterial pressure during sleep in Shy-Drager syndrome. Sleep 4:139–146.
  • Martinez-Nicolas A, Ortiz-Tudela E, Madrid JA, Rol MA. (2011). Crosstalk between environmental light and internal time in humans. Chronobiol. Int. 28:617–629.
  • McGinty D, Szymusiak R. (1994). Neurobiology of sleep. In Saunders NA, Sullivan CE (eds.). Sleep and breathing. New York: Marcel Dekker, 1–26.
  • Merillon JP, Passa P, Chastre J, Wolf A, Gourgon R. (1981). Left ventricular function and hyperthyroidism. Br. Heart J. 46:137–143.
  • Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol. Int. 30:145–158.
  • Montagna P, Cortelli P, Avoni P, Tinuper P, Plazzi G, Gallassi R, Portaluppi F, Julien J, Vital C, Delisle MB, Gambetti P, Lugaresi E. (1998). Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol. 8:515–520.
  • Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Chronobiol Int. 30:116–131.
  • Murillo JE, Tofler GH. (1997). Pathophysiology basis of cardiovascular circadian rhythmicity. In Deedwania PC (ed.). Circadian rhythms of cardiovascular disorders. Armonk, NY: Futura Publishing, 27–43.
  • Nathan PJ, Maguire KP, Burrows GD, Norman TR. (1997). The effect of atenolol, a beta-1 adrenergic antagonist, on nocturnal plasma melatonin excretion: evidence for a dose-response relationship in humans. J. Pineal Res. 23:131–135.
  • Nicolau GY, Haus E. (1992). Chronobiology of the hypothalamic-pituitary-thyroid axis. In Touitou Y, Haus E(eds.). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag, 331–347.
  • Nicholls MG, Espiner EA, Ikram H, Maslowski AH, Hamilton EJ, Bones PJ. (1984). Hormone and blood pressure relationships in primary aldosteronism. Clin. Exp. Hypertens. A 6:1441–1458.
  • Okamoto LE, Gamboa A, Shibao C, Black BK, Diedrich A, Raj SR, Robertson D, Biagggioni I. (2009). Hypertension 53:363–369.
  • Olofsson P. (1995). Characteristics of a reversed circadian blood pressure rhythm in pregnant women with hypertension. J. Hum. Hypertens. 9:565–570.
  • Otsuka A, Mikami H, Katahira K, Nakamoto Y, Minamitani K, Imaoka M, Nishide M, Ogihara T. (1990). Absence of nocturnal fall in blood pressure in elderly persons with Alzheimer-type dementia. J. Am. Geriatr. Soc. 38:973–978.
  • Paladizou E, Franey C, Arendt J, Stahl S, Checkley S. (1989). Evidence for a functional role of alpha-1 adrenoceptors in the regulation of melatonin secretion in man. Psychoneuroendocrinology 14:131–135.
  • Peliciari-Garcia RA, Zanquetta MM, Andrade-Silva J, Gomes DA, Barreto-Chaves ML, Cipolla-Neto J. (2011). Expression of circadian clock and melatonin receptors within cultured cardiomyocytes. Chronobiol. Int. 27:21–30.
  • Phillipson EA. (1978). Control of breathing during sleep. Am. Rev. Respir. Dis. 118:909–939.
  • Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646–649.
  • Plano SA, Golombek DA, Chiesa JJ. (2010). Circadian entrainment to light-dark cycles involves extracellular nitric oxide communication within the suprachiasmatic nuclei. Eur. J. Neurosci. 31:876–882.
  • Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940–951.
  • Portaluppi F, Lemmer B. (2007). Chronobiology and chronotherapy of ischemic heart disease. Adv. Drug Deliv. Rev. 59:952–965.
  • Portaluppi F, Smolensky MH. (2007). Circadian rhythmic and environmental determinants of 24-hour blood pressure regulation in normal and hypertensive conditions. In White WB (ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 135–158.
  • Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
  • Portaluppi F, Montanari L, Bagni B, degli Uberti E, Trasforini G, Margutti A. (1989). Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects. Cardiology 76:428–432.
  • Portaluppi F, Bagni B, degli Uberti E, Montanari L, Cavallini R, Trasforini G, Margutti A, Ferlini M, Zanella M, Parti M. (1990a). Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J. Hypertens. 8:85–95.
  • Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990b). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
  • Portaluppi F, Pradella A, Montanari L, degli Uberti E, Trasforini G, Margutti A, Cavallini AR, Bagni B. (1990c). Atrial strain is the main determinant of release of atrial natriuretic peptide. Int. J. Cardiol. 29:297–303.
  • Portaluppi F, Montanari L, Ferlini M, Vergnani L, D'Ambrosi A, Cavallini AR, Bagni B, degli Uberti E. (1991a). Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure. Chronobiol. Int. 8:432–439.
  • Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. (1991b). Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am. J. Hypertens. 4:20–26.
  • Portaluppi F, Montanari L, Ferlini M, Vergnani L, Bagni B, degli Uberti EC. (1992a). Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur. Heart J. 13:990–996.
  • Portaluppi F, Montanari L, Vergnani L, Tarroni G, Cavallini AR, Gilli P, Bagni B, degli Uberti EC. (1992b). Loss of nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure. Cardiology 80:312–323.
  • Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992c). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
  • Portaluppi F, Vergnani L, degli Uberti EC. (1993a). Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach. Chronobiol. Int. 10:176–189.
  • Portaluppi F, Vergnani L, Margutti A, Ambrosio MR, Bondanelli M, Trasforini G, Rossi R, degli Uberti EC. (1993b). Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. J. Clin. Endocrinol. Metab. 77:816–820.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994a). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569–576.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994b). Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia. J. Clin. Endocrinol. Metab. 78:1075–1078.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, Manfredini R, Montagna P, Gambetti P, Fersini C, Lugaresi E. (1995). Dissociated 24-h patterns of somatotropin and prolactin in fatal familial insomnia. Neuroendocrinology 61:731–737.
  • Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996a). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
  • Portaluppi F, Waterhouse J, Minors D. (1996b). The rhythms of blood pressure in humans. Exogenous and endogenous components and implications for diagnosis and treatment. Ann. N. Y. Acad. Sci. 783:1–9.
  • Portaluppi F, Cortelli P, Provini F, Plazzi G, Manfredini R, Lugaresi E. (1997a). Alterations of sleep and circadian blood pressure profile. Blood Press. Monit. 2:301–313.
  • Portaluppi F, Pansini F, Manfredini R, Mollica G. (1997b). Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 29:976–979.
  • Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, Fersini C, Lugaresi E. (1997c). Undiagnosed sleep-disordered breathing in male nondippers with essential hypertension. J. Hypertens. 15:1227–1233.
  • Portaluppi F, Manfredini R, Fersini C. (1999). From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events. Chronobiol. Int. 16:33–49.
  • Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
  • Portaluppi F, Cortelli P, Buonaura GC, Smolensky MH, Fabbian F. (2009). Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients? Chronobiol. Int. 26:1206–1221.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
  • Racke K, Krupa H, Schroder H, Vollrath L. (1989). In vitro synthesis of dopamine and noradrenaline in the isolated rat pineal gland: day-night variations and effects of electrical stimulation. J. Neurochem. 53:354–361.
  • Redfern PH, Lemmer B. (1997). Physiology and pharmacology of biological rhythms. Handbook of experimental pharmacology, Vol. 124. Berlin: Springer, 668 pp.
  • Redman CW, Beilin LJ, Bonnar J. (1976). Reversed diurnal blood pressure rhythm in hypertensive pregnancies. Clin. Sci. Mol. Med. 3:p687s–689s.
  • Reeves RA, Shapiro AP, Thompson ME, Johnsen AM. (1986). Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 73:401–408.
  • Reinberg A, Smolensky MH. (1983). Biological rhythms in medicine. Cellular metabolic, physiologic and pharmacologic aspects. Heidelberg: Springer-Verlag, 305 pp.
  • Reiter RJ. (1991). Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:151–180.
  • Revell VL, Barrett DCG, Schlangen LJM, Skene DJ. (2010). Predicting human nonvisual responses to monochromatic and polychromatic light with a melanopsin photosensitivity function. Chronobiol. Int. 27:1762–1777
  • Richards AM, Nicholls MG, Espiner EA, Ikram H, Cullens M, Hinton D. (1986). Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin. Exp. Hypertens. A 8:153–166.
  • Rossmanith WG, Mortola JF, Laughlin GA, Yen SS. (1988). Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women. J. Clin. Endocrinol. Metab. 67:560–564.
  • Rubin P, Blaschke TF, Guilleminault C. (1981). Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep. Circulation 63:117–121.
  • Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, for the VALUE Investigators. (2007). Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J. Hypertens. 25:1473–1479.
  • Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA. (1988). The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions. Arch. Gen. Psychiatry 45:162–166.
  • Sander D, Klingelhöfer J. (1993). Circadian blood pressure patterns in four cases with hemodynamic brain infarction and prolonged blood-brain barrier disturbance. Clin. Neurol. Neurosurg. 95:221–229.
  • Sander D, Klingelhöfer J. (1994). Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 25:1730–1737.
  • Scanlon MF, Weetman AP, Lewis M, Pourmand M, Rodriguez-Arnao MD, Weightman DR, Hall R. (1980). Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects. J. Clin. Endocrinol. Metab. 51:1251–1256.
  • Semba J, Toru M, Mataga N. (1984). Twenty-four hour rhythms of norepinephrine and serotonin in nucleus suprachiasmaticus, raphe nuclei, and locus coeruleus in the rat. Sleep 7:211–218.
  • Shaw DB, Knapp MS, Davies DH. (1963). Variations in blood pressure in hypertensives during sleep. Lancet 1:797–799.
  • Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. (2002). Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am. J. Hypertens. 15:111–118.
  • Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. (1992). Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens. 10:875–878.
  • Sica DA. (1999). What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure? Blood Press. Monit. 4( Suppl 2):S9–S16.
  • Sirota JH, Baldwin DS, Villareal H. (1950). Diurnal variations of renal function in man. J. Clin. Invest. 29:187–192.
  • Smolensky MH, Lamberg L. (2000). The body clock guide to better health. New York: Henry Holt & Co., 428 pp.
  • Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14–S24.
  • Smolensky MH, Tatar SE, Bergman SA, Losman, JG, Barnard CN, Dacso CC, Kraft IA. (1977). Circadian rhythmic aspects of cardiovascular function. A review by chronobiologic statistical methods. Chronobiologia 3:337–371.
  • Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
  • Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
  • Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg, Germany: Springer-Verlag, 359–443.
  • Snyder F, Hobson A, Morrison DF, Goldfrank F. (1964). Changes in respiration, heart rate and systolic blood pressure in human sleep. J. Appl. Physiol. 19:417–422.
  • Soergel M, Maisin A, Azancot-Benisty A, Loirat C. (1992). Ambulante Blutdruckmessung bei nierentransplantierten Kindern und Jugendlichen. Z. Kardiol. 81:67–70.
  • Son GH, Chung S, Choe HK, Kim HD, Baik SM, Lee H, Lee HW, Choi S, Sun W, Kim H, Cho S, Lee KH, Kim K. (2008). Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc. Natl. Acad. Sci. U. S. A. 105:20970–20975.
  • Sothern RB, Vesely DL, Kanabrocki EL, Hermida RC, Bremner FW, Third JL, Boles MA, Nemchausky BM, Olwin JH, Scheving LE. (1995). Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 12:106–120.
  • Späth-Schwalbe E, Uthgenannt D, Voget G, Kern W, Born J, Fehm H-L. (1993). Corticotropin-releasing hormone induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J. Clin. Endocrinol. Metab. 77:1170–1173.
  • Statius van Eps RG, van den Meiracker AH, Boomsma F, Man in't Veld AJ, Schalekamp MADH. (1994). Diurnal variation of blood pressure in patients with catecholamine-producing tumors. Am. J. Hypertens. 7:492–497.
  • Stehle JH, Foulkes NS, Molina CA, Simonneaux V, Pevet P, Sassone-Corsi P. (1993). Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature 365:314–320.
  • Stoschitzky K, Sakotnik K, Lercher P, Zweiker R, Maier R, Liebmann P, Linder W. (1999). Influence of beta blockers on melatonin release. Eur. J. Clin. Pharmacol. 55:111–115.
  • Stratmann M, Schibler U. (2006). Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J. Biol. Rhythms 21:494–506.
  • Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H. (1988). Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11:78–83.
  • Takeda N, Maemura K. (2011). Circadian clock and cardiovascular disease. J. Cardiol. 57:249–256.
  • Teerlink JR, Clozel JP. (1993). Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am. J. Physiol. 264(6 Pt 2):H2111–H2118.
  • Tempel DL, Leibowitz SF. (1990). Diurnal variations in the feeding responses to norepinephrine, neuropeptide Y and galanin in the PVN. Brain Res. Bull. 25:821–825.
  • Thoren P, Floras JS, Hoffman P, Seals DR. (1990). Endorphins and exercise: physiological mechanisms and clinical implications. Med. Sci. Sports Exerc. 22:417–428.
  • Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. (1976). Hemodynamics in sleep-induced apnea Studies during wakefulness and sleep. Ann. Intern. Med. 85:714–719.
  • Tohgi H, Chiba K, Kimura M. (1991). Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. Stroke 22:603–608.
  • Touitou Y, Haus E(eds.). (1992). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag, 730 pp.
  • Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
  • Tsimakouridze EV, Straume M, Podobed PS, Chin H, LaMarre J, Johnson R, Antenos M, Kirby GM, Mackay A, Huether P, Simpson JA, Sole M, Gadal G, Martino TA. (2012). Chronomics of pressure overload induced cardiac hypertrophy in mice reveals altered day/night gene expression in heart disease. Chronobiol. Int. 29: 810–821.
  • Tsioufis C, Andrikou I, Thomopoulos C, Petras D, Manolis A, Stefanadis C. (2011). Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes. Am. J. Nephrol. 33:277–288.
  • Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. (1991). Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 88:934–942.
  • van de Borne P, Gelin M, Van de Stadt J, Degaute JP. (1993a). Circadian rhythms of blood pressure after liver transplantation. Hypertension 21:398–405.
  • van de Borne P, Tielemans C, Collart F, Vanherweghem JL, Degaute JP. (1993b). Twenty-four-hour blood pressure and heart rate patterns in chronic hemodialysis patients. Am. J. Kidney Dis. 22:419–425.
  • Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999a). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
  • Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999b). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499–2502.
  • Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285–289.
  • Vaughan GM, Allen JP, Tullis W, Siler-Khodr TM, de la Pena A, Sackman JW. (1978). Overnight plasma profiles of melatonin and certain adenohypophyseal hormones in men. J. Clin. Endocrinol. Metab. 47:566–571.
  • Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. (1990). Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536.
  • Viñolas X, Moya A, Cinca J, Bayés de Luna A. (1997). Circadian variations in Electrophysiological parameters and cardiac repolarization. In Deedwania PC(ed.). Circadian rhythms of cardiovascular disorders. Armonk, NY: Futura Publishing, pp. 71–94.
  • Viswambharan H, Carvas JM, Antic V, Marecic A, Jud C, Zaugg CE, Ming XF, Montani JP, Albrecht U, Yang Z. (2007). Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 115:2188–2195.
  • Weekley LB. (1993). Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin. Auton. Res. 3:45–47.
  • Welsh DK, Takahashi JS, Kay SA. (2010). Suprachiasmatic nucleus: cell autonomy and network properties. Annu. Rev. Physiol. 72:551–577.
  • White WB, Malchoff C. (1992). Diurnal blood pressure variability in mineralocorticoid excess syndrome. Am. J. Hypertens. 5:414–418.
  • Witworth JA, Saines D, Thatcher R, Burtkus A, Scoggins BA. (1983). Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man. Clin. Exp. Hypertens. A 5:501–522.
  • Yoshida T, Bray GA. (1988). Effects of food and light on norepinephrine turnover. Am. J. Physiol. 254(5 Pt 2):R821–R827.
  • Zelinka T, Strauch B, Pecen L, Widimsky J (2004). Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J. Hum. Hypertens. 18:107–111.
  • Zeman M, Dulková K, Bada V, Herichová I. (2005). Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci. 76:1795–1803.
  • Zoccoli G, Grant DA, Wild J, Walker AM. (2001). Nitric oxide inhibition abolishes sleep–wake differences in cerebral circulation. Am. J. Physiol. Heart Circ. Physiol. 280:H2598–H2606.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.